EGFR and neoplasm: Further, tumor uptake of [89Zr]ZrDFO-amivantamab was significantly higher than those of the radiolabeled single-arm parent antibodies [89Zr]ZrDFO-α-EGFR or [89Zr]ZrDFO-α-c-MET.